Sail Biomedicines

We’re looking forward to the mRNA-Based Therapeutics Summit in Boston next week, where our team will be participating in a panel discussion and giving a presentation. 🗓️ Tuesday, July 30th, 8:30 am ET Igor Matushansky, M.D., Ph.D., Sail’s Chief Medical Officer, will be on the CXOs Panel Discussion: Unlocking the Next Frontiers of mRNA-Based Vaccines & Therapeutics to Ensure Better Drugs Reach Patients Faster 🎤 Wednesday, July 31st, 12:15 pm ET Francis Poulin, Ph.D., Sail’s VP, Analytical Sciences will give a talk titled, “Process & Analytical Development Advances for eRNA Therapeutics.” See more details on the conference website: https://lnkd.in/ekvueFm #eRNA #RNA #endlessRNA

Companies pioneering original science are essential to generate tomorrow's medicines today. We are proud to be one with the first fully programmable #RNA medicines platform and to be part of the #FlagshipFounded ecosystem of companies and the many more to come. #eRNA #endlessRNA

🌈 At Sail, we're proud to support and celebrate our diverse team every day, and our recent Pride Happy Hour was certainly a happy event, with fun activities like Pride Trivia and Paint Your Pride fostering a spirit of inclusion and community - and a little bit of Celtics team pride thrown in too. A huge thank you to everyone who participated and made this event memorable. Happy #Pride2024! 🏳️🌈 #OneSail #LGBTQIA2S+ #diversityandinclusion 

June is a time of celebration, remembrance, & intersectional allyship, and we were honored to welcome members of SpeakOUT Boston, the nation's oldest #LGBTQIA2S+ speakers bureau, to Sail HQ to host a panel discussion as part of our #PrideMonth & #Juneteenth celebrations. The speakers Francis Miranda, Jennifer Stephens, and Tad Read - moderated by Ellyn Ruthstrom - gave inspiring accounts of their lived experiences navigating multiple cultural spheres in society and their careers, and the "Ask Us Anything" format provided a great opportunity to engage in honest dialogue. #OneSail #DEI #DEIB #diversityandinclusion #equity #InclusionMatters

At Sail, we believe in nurturing both health and the environment. That's why we dedicated #EarthDay to planting seeds of sustainability while fostering community and conservation  through our Plant and Paint event. Here are some snapshots of this fun event #OneSail

Siddharth Patel, Ph.D., Sail’s Director of Formulation and Delivery Sciences, will be presenting in Boston next week at the 16th Drug Discovery Strategic Summit. His keynote talk titled, “The title is “Pioneering the Design and Deployment of Fully Programmable RNA Medicines,” will take place on Thursday, May 9th at 2:20pm ET. Learn more about the conference here: https://lnkd.in/dr6rcekp #eRNA #RNA #endlessRNA #drugdelivery #genedelivery #nanoparticles #RNAtherapeutics

Francis Poulin, Ph.D., Sail’s VP, Analytical Sciences will be presenting in Boston next week at the 3rd Annual Next Generation RNA Therapeutics Summit. Check out his talk on May 9th titled, “Analytical Development of Circular RNA & Novel AEX-HPLC Purity Method for Endless RNA™.” See the full agenda here: https://lnkd.in/eMCej-ue #eRNA #RNA #endlessRNA 

We are excited to share that we’ve had a poster accepted for presentation at #ASGCT24 which shows how eRNA™ – with prolonged protein expression – can expand the therapeutic potential for #RNA medicines. The novel combination found in Sail’s platform of #eRNA and delivery has the potential to create optimized #geneticmedicines. See our abstract here: https://lnkd.in/gmNrMjZg #endlessRNA 

We are pleased to welcome Dr. Wendy Chung to Sail’s Board of Directors. Dr. Chung currently serves as Chief of the Department of Pediatrics of Boston Children’s Hospital, sits on the faculty at Harvard Medical School, and is President of the Children’s Hospital Pediatric Associates. She brings 20+ years of experience as a clinical and molecular geneticist, as well as biotech operational experience. Read the press release here: https://lnkd.in/gmzt-i9b #eRNA #EndlessRNA

Exciting to see @Flagship Pioneering named one of the world’s most innovative companies by Fast Company three years in a row. We’re proud to be #FlagshipFounded as we advance our platform to generate tomorrow's medicines today! #programmablemedicines #biggerleaps